Holen Sie sich die Stockscreener-App
27.10
4.59%
1.19
Handel nachbörslich:
26.91
-0.19
-0.70%
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
Greenwich Lifesciences Provides Clinical Trial and Pipeline Update - National Today
Strategic financing update revealed by Greenwich LifeSciences - Traders Union
Greenwich LifeSciences reports Q1 cash balance of $10.5 million By Investing.com - Investing.com India
Greenwich LifeSciences, Inc. Provides Financial Updates and Progress on FLAMINGO-01 Phase III Trial for Breast Cancer Immunotherapy GLSI-100 - Quiver Quantitative
Greenwich LifeSciences reports Q1 cash balance of $10.5 million - Investing.com
Greenwich LifeSciences Provides Update on Financing Strategy - ChartMill
Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Tuesday - MarketBeat
Portfolio Shifts: Can Greenwich LifeSciences Inc expand into new markets2026 Recap & Detailed Earnings Play Strategies - baoquankhu1.vn
Greenwich Lifesciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView — Track All Markets
Aug Retail: Will Greenwich LifeSciences Inc benefit from current market trendsTrade Risk Assessment & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Will Greenwich LifeSciences Inc benefit from current market trends2026 Market Outlook & Weekly Hot Stock Watchlists - baoquankhu1.vn
(GLSI) Risk Channels and Responsive Allocation - Stock Traders Daily
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - ADVFN
GLSI Technical Analysis | Trend, Signals & Chart Patterns | GREENWICH LIFESCIENCES INC (NASDAQ:GLSI) - ChartMill
Greenwich LifeSciences: 'Buy' On Recent Open-Label Data And Patent Claim - Seeking Alpha
Greenwich LifeSciences files patent claims for breast cancer therapy By Investing.com - Investing.com South Africa
Greenwich LifeSciences advances new patent claims after FLAMINGO-01 data show statistically significant immune response - Traders Union
Greenwich LifeSciences files patent claims for breast cancer therapy - Investing.com
Greenwich Lifesciences Provides Update On Patent Claims Potentially Doubling Gp2 Market Potential - TradingView
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential - The Manila Times
Greenwich LifeSciences Provides Update On Patent Claims Potentially Doubling GP2 Market Potential - marketscreener.com
Valuation Update: Can Greenwich LifeSciences Inc expand into new marketsMarket Sentiment Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Greenwich LifeSciences Delays Annual SEC Filing - TipRanks
Greenwich LifeSciences (GLSI) notifies SEC of late 10-K, cites higher R&D - Stock Titan
Sell Signal: What are the future prospects of Greenwich LifeSciences Inc2026 Market Overview & Long-Term Investment Growth Plans - baoquankhu1.vn
(GLSI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Greenwich LifeSciences (GLSI) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Aug Analyst Calls: What are the future prospects of Greenwich LifeSciences IncPortfolio Value Summary & Real-Time Market Trend Scan - baoquankhu1.vn
Why Is GLSI Stock Rising Today? - Dailyhunt
If You Invested $1,000 in Greenwich Lifesciences Inc (GLSI) - Stock Titan
Retail Trends: Is Greenwich LifeSciences Inc undervalued by DCF analysisGold Moves & Weekly Top Performers Watchlists - baoquankhu1.vn
Treasury Yields: Is Greenwich LifeSciences Inc a turnaround storyWeekly Profit Analysis & Long Hold Capital Preservation Plans - baoquankhu1.vn
Greenwich LifeSciences expands Phase III trial to City of Hope sites - ca.investing.com
Greenwich LifeSciences Inc initiates new US clinical sites for Flamingo-01 phase III trial - marketscreener.com
Greenwich LifeSciences, Inc. Announces Addition of City of Hope to Flamingo-01 - marketscreener.com
Greenwich LifeSciences Expands FLAMINGO-01 Trial to City of Hope - National Today
Greenwich LifeSciences expands Phase III trial to City of Hope sites By Investing.com - Investing.com India
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 - ChartMill
Liquidity Mapping Around (GLSI) Price Events - Stock Traders Daily
Greenwich LifeSciences to present trial data at AACR meeting By Investing.com - Investing.com South Africa
Greenwich LifeSciences to present trial data at AACR meeting - Investing.com
Greenwich Lifesciences provides update on upcoming AACR meeting - marketscreener.com
Greenwich Lifesciences Provides Update On Upcoming Aacr Meeting - TradingView
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting - manilatimes.net
Greenwich LifeSciences, Inc. Announces Presentation of FLAMINGO-01 Phase III Clinical Trial Data at AACR Meeting 2026 - Quiver Quantitative
Greenwich LifeSciences to share AACR Meeting plans - Traders Union
Greenwich LifeSciences reports reduced cancer recurrence in trial By Investing.com - Investing.com South Africa
Why is GLSI stock rising today? - MSN
Breakthrough in Clinical Trial Data: Biopharmaceutical company Greenwich Lifesciences Inc (NASDAQ: GLSI) recently announced the latest analysis results of its core immunotherapy GP2 in adjuvant treatment for breast cancer. - Bitget
Greenwich LifeSciences reports reduced cancer recurrence in trial - Investing.com
0.45%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):